Dipexium Pharmaceuticals (DPRX) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts DPRX Hot Sheet
Join SI Premium – FREE
Dipexium Pharmaceuticals (NASDAQ: DPRX) reported Q2 EPS of ($0.47), $0.04 worse than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Dipexium Pharmaceuticals (DPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Ross Stores raises 2026 outlook after strong second-quarter results
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
